Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04437511 |
|---|---|
| Brief Title: | A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) |
| First Submitted : | June 17, 2020 |
| First Submitted that Met QC Criteria : | June 17, 2020 |
| First Posted : | June 18, 2020 |
| Last Update Submitted that Met QC Criteria : | March 13, 2024 |
| Last Update Posted : | March 15, 2024 |